Guangzhou Baiyunshan Pharmaceutical Holdings manufactures and sells Chinese patent medicine.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 23, 2022 | Post-IPO Equity | $1.43M | 1 | Source Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Source Capital | Yes | Post-IPO Equity |